Survival and pathological response in pancreatic ductal adenocarcinoma after preoperative therapy with PD-1 blockade plus chemoradiotherapy followed by surgical resection
Sign Up to like & getrecommendations! Published in 2025 at "Annals of Medicine"
DOI: 10.1080/07853890.2025.2541314
Abstract: Abstract Background Neoadjuvant PD-1 blockade plus chemoradiotherapy has resulted in improved clinical response in pancreatic ductal adenocarcinoma (PDAC); however, the effects on pathological response (PR) and survival remain unknown. This study was to identify the… read more here.
Keywords: blockade plus; plus chemoradiotherapy; combined group; response ... See more keywords
The efficacy of plasma exosomal miRNAs as predictive biomarkers for PD-1 blockade plus chemotherapy in gastric cancer
Sign Up to like & getrecommendations! Published in 2024 at "Translational Cancer Research"
DOI: 10.21037/tcr-24-2151
Abstract: Background The response of gastric cancer (GC) patients to first-line programmed cell death 1 (PD-1) blockade and S-1 plus oxaliplatin (SOX) chemotherapy varies considerably, and the underlying mechanisms driving this variability remain elusive. Exosomal microRNAs… read more here.
Keywords: cancer; gastric cancer; predictive biomarkers; plasma exosomal ... See more keywords